| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5COW40EV8M |
| InChI Key | ZVNYJIZDIRKMBF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H25N3O4 |
| Molecular Weight | 395.46 |
| AlogP | 2.55 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 71.11 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Phosphodiesterase
Phosphodiesterase 3
Phosphodiesterase 3A
|
- | 10700-11210 | - | - | - | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 3
Phosphodiesterase 3B
|
- | 13200-14540 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 1097-18000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| HIV Infections | 1 | D015658 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 81840-15-5 |
| ChEBI | 31237 |
| ChEMBL | CHEMBL17423 |
| DrugBank | DB12082 |
| DrugCentral | 2817 |
| EPA CompTox | DTXSID80231411 |
| FDA SRS | 5COW40EV8M |
| Human Metabolome Database | HMDB0042059 |
| PubChem | 5663 |
| SureChEMBL | SCHEMBL50993 |
| ZINC | ZINC000003781942 |